INTRODUCTION
Sepsis, a life-threatening organ dysfunction caused by a dysregulated host response to infection, affects individuals across all age groups.(1) Still, older adults bear a disproportionate burden.(2) Physiological changes associated with age, frailty, multimorbidity, and atypical presentations increase vulnerability. Despite this, Emergency Departments (ED) and intensive care units (ICU) remain poorly adapted to their needs.(3) This viewpoint proposes a geriatric-based approach across the sepsis continuum to address these gaps (Figure 1).
A geriatric pathway for sepsis: from vulnerability and diagnostic pitfalls to adapted bundles, frailty-triggered actions, and prevention.
WHY ARE OLDER ADULTS MORE VULNERABLE TO SEPSIS?
Aging impairs innate and adaptive immunity ("immunosenescence"). It increases baseline inflammatory activation ("inflammageing"), reducing pathogen clearance, the ability to regulate systemic inflammation, and recovery after an acute insult, contributing to persistent organ dysfunction. Notwithstanding, understanding the immune system's aging process will lead to new prevention or treatment strategies, as recently reviewed.(4)
WHAT ARE THE DETERMINANTS OF MISDIAGNOSIS OF SEPSIS IN OLDER INDIVIDUALS?
Classical signs such as fever and leucocytosis may be absent in older individuals, while nonspecific symptoms – delirium, weakness, anorexia, and acute functional decline – are easily misattributed to aging. Sepsis mimics, such as acute heart failure or pulmonary embolism, presenting with shock and elevated lactate, complicate sepsis recognition. Moreover, interpreting inflammatory biomarkers is difficult due to comorbidities, including chronic renal dysfunction.(5) Ultimately, clinical acumen and structured geriatric assessment, understanding the role of altered mental state in the sepsis diagnosis, remain irreplaceable.
MICROBIOLOGICAL DIAGNOSIS AND AGE-RELATED AETIOLOGIES
Causative pathogens shift with aging: Gram-negative bacilli such as Escherichia coli and Klebsiella spp., predominate, especially in urinary infections, whereas Staphylococcus aureus and Streptococcus pneumoniae remain important but less prevalent.(6) Polypharmacy, indwelling devices, and prior healthcare exposure increase the likelihood of multidrug-resistant organisms or unusual pathogens.(7) This highlights the need not to discard invasive microbiological sampling to guide antibiotic therapy.
DO CURRENT BUNDLES FIT THIS POPULATION?
Although the Surviving Sepsis Campaign guidelines are foundational,(1) most evidence has a limited representation of frail and older adults. A geriatric-based approach should adapt resuscitation, airway, and transfusion management to the older population's needs and focus on the 5Ms approach (Mobility, Mind, Multicomplexity, Medications, Matters Most)(8) to promote an aggressive strategy for recovery and the prevention of complications (Figure 1).
FLUID MANAGEMENT
In older adults, fluid tolerance may be reduced due to diastolic dysfunction, reduced renal function, and impaired autonomic regulation. Over 30mL/kg fluid loading may precipitate acute heart and kidney failure, cerebral edema, whereas conservative resuscitation risks hypoperfusion and multi-organ failure. As such, although initial fluids should not be delayed or withheld, monitoring based on ultrasound or even thermodilution methods should not be denied to this population to prevent both under- and over-resuscitation.(9)
VASOPRESSOR THERAPY
Although norepinephrine remains first-line, this population is more susceptible to arrhythmias and myocardial ischemia at higher vasopressor doses. The OPTPRESS trial found no benefit from higher mean arterial pressure (MAP) targets (80 - 85mmHg), even suggesting potential harm in older hypertensive patients.(10) In the 65-trial enrolling patients aged ≥ 65 years, reduced vasopressor exposure, aiming for MAP 60 - 65mmHg, was not associated with increasing mortality.(11) These data reinforce that higher MAP goals should not be routinely pursued, and that a standard target around 65mmHg is appropriate, with adjustments in the presence of persistent signs of hypoperfusion.
CORTICOSTEROID ADJUVANT THERAPY
Corticosteroid adjuvant therapy for refractory shock must be carefully considered. Overall, the risk of adverse events in older adults, including ICU-acquired weakness, dysglycemia, and neuro-psychiatric events, might be higher.(12) Nevertheless, age analysis was not considered in recent systematic reviews.(13)
TRANSFUSION THRESHOLDS
The optimal transfusion threshold in sepsis remains debated. Emerging evidence suggests that intermediate targets (Hemoglobin 7 - 9g/dL) may improve outcomes in older patients,(14) eventually guided by the arterial-venous oxygen difference.(15)
AIRWAY AND INTUBATION CONSIDERATIONS IN OLDER ADULTS
The indications for endotracheal intubation in sepsis include respiratory failure, hemodynamic collapse, altered mental status, and surgical source control. In the multicentre INTUBE study, age was an independent risk factor for peri-intubation cardiovascular instability or collapse.(16) Anatomical and physiological changes associated with aging –reduced cervical spine mobility, diminished pharyngeal muscle tone, presbyphagia, and increased aspiration risk – compound the difficulty of airway management in older patients.(17) These underscore the need to anticipate a difficult airway, optimize the hemodynamics before induction, and consider awake or modified induction strategies in older adults with sepsis.
OPERATIONALIZING FRAILTY AT ADMISSION
Frailty assessment should be embedded in the sepsis admission evaluation, regardless of age. However, given the higher prevalence of frailty in older patients, the Clinical Frailty Scale (CFS), a nine-point tool that assesses global vulnerability, is particularly relevant for measuring baseline vulnerability. Importantly, frailty should not just be descriptive; it should guide concrete management steps. Such operationalization transforms frailty from a conceptual risk marker into a practical decision-making framework for acute sepsis care.(18) Observational data confirm that frailty, rather than age alone, is the main predictor of ICU and hospital mortality even for the oldest old patients (more than 90 years old admitted to the ICU).
All patients with severe frailty (CFS ≥ 7) should have goals-of-care discussions, aligning treatment with patients’ values and a realistic prognosis. A multidisciplinary team approach, with ICU, geriatricians, and palliative care physicians, may provide further benefit.(19)
BEYOND SURVIVAL: RECOVERY AND LONG-TERM SEQUELAE
Among survivors aged ≥ 65 years, sepsis often triggers a cascade of decline, new disabilities in activities of daily living, persistent cognitive impairment, institutionalization, and need for hospital readmission. These outcomes are mediated not only by the severity of the acute insult but also by baseline frailty and sarcopenia, as well as institutional standard of care.(3) Strategies to prevent a fast decline after the event must be considered early on, such as rehabilitation to preserve mobility and delirium prevention bundles, minimizing the use of deliriogenic drugs, and maximizing the presence of family and caregivers. Although recommended for all patients, older adults may be perceived to have less benefit from being included in such an aggressive rehabilitation strategy.(20)
CONCLUSION
The interplay of aging physiology, frailty, and multimorbidity shapes sepsis in older adults. Integrating a geriatric lens – grounded in frailty assessment, individualized hemodynamic stabilization, and recovery-focused care – offers a realistic, clinically meaningful path toward improved outcomes for older adults with sepsis, with a focus on functional recovery and quality of life.
ACKNOWLEDGEMENTS
We would like to acknowledge all the geriatrics and intensivists who work together to decrease the burden of aging in septic patients.
AVAILABILITY OF DATA AND MATERIALS
The contents underlying the research text are included in the manuscript.
REFERENCES
- 1 Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Crit Care Med. 2021;49(11):e1063-143.
- 2 Margalit I, Yahav D, Hoffman T, Tabah A, Ruckly S, Barbier F, et al.; EUROBACT-2 Study Group, the European Society of Intensive Care Medicine (ESICM), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Groups for Infections in Critically Ill Patients (ESGCIP) and Infections in the Elderly (ESGIE), and the OUTCOMEREA Network. Presentation, management, and outcomes of older compared to younger adults with hospital-acquired bloodstream infections in the intensive care unit: a multicenter cohort study. Infection. 2024;52(6):2435-43.
- 3 Warmerdam M, Stolwijk F, Boogert A, Sharma M, Tetteroo L, Lucke J, et al. Initial disease severity and quality of care of emergency department sepsis patients who are older or younger than 70 years of age. PLoS One. 2017;12(9):e0185214.
- 4 Wang Y, Zhang H, Miao C. Unraveling immunosenescence in sepsis: from cellular mechanisms to therapeutics. Cell Death Dis. 2025;16(1):393.
- 5 Póvoa P, Coelho L, Dal-Pizzol F, Ferrer R, Huttner A, Conway Morris A, et al. How to use biomarkers of infection or sepsis at the bedside: guide to clinicians. Intensive Care Med. 2023;49(2):142-53.
- 6 Rowe TA, Juthani-Mehta M. Urinary tract infection in older adults. Aging Health. 2013;9(5):519-28.
- 7 Sahuquillo-Arce JM, Menéndez R, Méndez R, Amara-Elori I, Zalacain R, Capelastegui A, et al. Age-related risk factors for bacterial aetiology in community-acquired pneumonia. Respirology. 2016;21(8):1472-9.
- 8 Cozza M, Paglia A, Dini S, Di Francesco V, Dal Santo P, Boccardi V. The comprehensive geriatric assessment in emergency and intensive unit settings. Geriatr Care. 2024;10(1):12156.
- 9 Gu T, Min Y, Zhang L, Jin F, Liu F. Impact of 30 mL/kg fluid resuscitation completed within one hour on elderly septic shock patient. Ann Med. 2025;57(1):2445778.
- 10 Endo A, Yamakawa K, Tagami T, Umemura Y, Wada T, Yamamoto R, et al.; OPTPRESS trial investigators. Efficacy of targeting high mean arterial pressure for older patients with septic shock (OPTPRESS): a multicentre, pragmatic, open-label, randomised controlled trial. Intensive Care Med. 2025;51(5):883-92.
- 11 Lamontagne F, Richards-Belle A, Thomas K, Harrison DA, Sadique MZ, Grieve RD, et al.; 65 trial investigators. Effect of reduced exposure to vasopressors on 90-day mortality in older critically ill patients with vasodilatory hypotension: a randomized clinical trial. JAMA. 2020;323(10):938-49.
- 12 Noetzlin S, Breville G, Seebach JD, Gastaldi G. Short-term glucocorticoid-related side effects and adverse reactions: a narrative review and practical approach. Swiss Med Wkly. 2022;152:w30088.
- 13 Pitre T, Drover K, Chaudhuri D, Zeraaktkar D, Menon K, Gershengorn HB, et al. Corticosteroids in sepsis and septic shock: a systematic review, pairwise, and dose-response meta-analysis. Crit Care Explor. 2024;6(1):e1000.
- 14 Permpikul C, Tanksinmankhong J, Tongyoo S, Naorungroj T, Viarasilpa T, Karaketklang K. Optimal hemoglobin threshold for blood transfusions in sepsis and septic shock: a retrospective analysis. Intern Emerg Med. 2025;20(3):829-39.
- 15 Fogagnolo A, Taccone FS, Vincent JL, Benetto G, Cavalcante E, Marangoni E, et al. Using arterial-venous oxygen difference to guide red blood cell transfusion strategy. Crit Care. 2020;24(1):160.
- 16 Russotto V, Tassistro E, Myatra SN, Parotto M, Antolini L, Bauer P, et al. Peri-intubation cardiovascular collapse in patients who are critically ill: insights from the INTUBE Study. Am J Respir Crit Care Med. 2022;206(4):449-58.
- 17 Johnson KN, Botros DB, Groban L, Bryan YF. Anatomic and physiopathologic changes affecting the airway of the elderly patient: implications for geriatric-focused airway management. Clin Interv Aging. 2015;10:1925-34.
- 18 Guidet B, de Lange DW, Boumendil A, Leaver S, Watson X, Boulanger C, et al.; VIP2 study group. The contribution of frailty, cognition, activity of daily life and comorbidities on outcome in acutely admitted patients over 80 years in European ICUs: the VIP2 study. Intensive Care Med. 2020;46(1):57-69.
- 19 Correia I, Simas Â, Chaves S, Paixão AI, Catarino A, Gonçalves-Pereira J. The PALliative MUlticenter Study in Intensive Care (PalMuSIC). Results From a Multicenter Study Addressing Frailty and Palliative Care Interventions in Intensive Care Units in Portugal. J Palliat Care. 2022;37(4):552-61.
- 20 Jacobs JM, Rahamim A, Beil M, Guidet B, Vallet H, Flaatten H, et al. Critical care beyond organ support: the importance of geriatric rehabilitation. Ann Intensive Care. 2024;14(1):71.
Edited by
-
Responsible editor:
Thiago Costa Lisboa https://orcid.org/0000-0003-4306-2212


